Skip to main content


Page 1 of 1

  1. Cellular heterogeneity in tumor cells is a well-established phenomenon. Genetic and phenotypic cell-to-cell variability have been observed in numerous studies both within the same type of cancer cells and acro...

    Authors: Yang Shen, B. U. Sebastian Schmidt, Hans Kubitschke, Erik W. Morawetz, Benjamin Wolf, Josef A. Käs and Wolfgang Losert
    Citation: Cancer Convergence 2020 4:1
  2. Microfluidic platforms have demonstrated the ability to isolate rare circulating tumor cells from a wide variety of cancers. Our group has recently shown the ability to isolate circulating tumor cells (CTCs) f...

    Authors: Rahmi Oklu, Rahul Sheth, Hassan Albadawi, Irun Bhan, A. Fatih Sarioglu, Melissa Choz, Mahnaz Zeinali, Vikram Deshpande, Shyamala Maheswaran, Daniel A. Haber, Shannon L. Stott, Andrew X. Zhu, Lipika Goyal, Mehmet Toner and David T. Ting
    Citation: Cancer Convergence 2018 2:2
  3. The physics of cancer dormancy, the time between initial cancer treatment and re-emergence after a protracted period, is a puzzle. Cancer cells interact with host cells via complex, non-linear population dynam...

    Authors: Amy Wu, David Liao, Vlamimir Kirilin, Ke-Chih Lin, Gonzalo Torga, Junle Qu, Liyu Liu, James C. Sturm, Kenneth Pienta and Robert Austin
    Citation: Cancer Convergence 2018 2:1
  4. Mechanistic models of within-cell signal transduction networks can explain how these networks integrate internal and external inputs to give rise to the appropriate cellular response. These models can be fruit...

    Authors: Jorge Gómez Tejeda Zañudo, Maurizio Scaltriti and Réka Albert
    Citation: Cancer Convergence 2017 1:5
  5. Why does a tumor start where it does within an organ? Location is traditionally viewed as a random event, yet the statistics of the location of tumors argues against this being a random occurrence. There are n...

    Authors: Clare Yu and James Kameron Mitchell
    Citation: Cancer Convergence 2017 1:4
  6. The Epithelial-Mesenchymal Transition (EMT) endows epithelial-looking cells with enhanced migratory ability during embryonic development and tissue repair. EMT can also be co-opted by cancer cells to acquire m...

    Authors: Dongya Jia, Mohit Kumar Jolly, Satyendra C. Tripathi, Petra Den Hollander, Bin Huang, Mingyang Lu, Muge Celiktas, Esmeralda Ramirez-Peña, Eshel Ben-Jacob, José N. Onuchic, Samir M. Hanash, Sendurai A. Mani and Herbert Levine
    Citation: Cancer Convergence 2017 1:2